Tumor-informed, circulating tumor DNA-based molecular residual disease preceded disease-free survival events by a median of 4.7 months. HealthDay News — For patients with resected stage IB-IIIA ...

"It wouldn't be anything if it was just me," he said. "It's also people who give me their old boards - interacting with the art and letting me be involved with things is what's kept it going.